View Intercept Pharmaceuticals, Inc. (ICPT) options listings by expiration date.
Dak Prescott Dallas Cowboys DraftDive deeper with interactive charts and top stories of Intercept Pharmaceuticals Inc.
On May 19, Intercept Pharmaceuticals Inc (NASDAQ: ICPT) announced plans for an international Phase 3 trial of OCA in patients with NASH.You may automatically receive Intercept Pharmaceuticals, Inc. financial information by email.Intercept Pharma (ICPT) stock is falling on Friday afternoon as Morgan Stanley downgraded the.
ICPT, Intercept Pharmaceuticals stock charts with technical analysis indicators.The Investor Relations website contains information about Intercept Pharmaceuticals, Inc. business for stockholders, potential investors, and financial analysts.Intercept Pharmaceuticals, Inc (ICPT - Analyst Report) is slated to report its third-quarter 2014 results on Nov 7.Intercept Pharmaceuticals Inc Stock Rating, Sentiment and Fundamentals.
Community Stock Ratings for Intercept Pharmaceuticals, Inc. (ICPT) - See ratings for ICPT from other NASDAQ Community members and submit your own rating for ICPT.Learn about the latest company events and happenings for Intercept Pharmaceuticals, Inc. (ICPT).
Intercept Pharmaceuticals Makes a Breakthrough (ICPT)
Stock ), of Intercept Pharmaceuticals, Inc. options to purchase shares of Common Stock, which o ptions are exercisable as of the date of this filin g.Live stock market trading videos on ICPT Intercept Pharmaceutical.Detailed stock trading history of Williams Nicole (Intercept Pharmaceuticals Inc ).Get the latest INTERCEPT PHARM ICPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Free Online Penny Stock Brokers
Intercept Pharmaceuticals Inc, ICPT real time stock quotes, news, videos at CNBC.com.Stock Analysis New York City based Intercept Pharmaceuticals was founded in 2002 and is a biopharmaceutical company specializing in developing and commercializing new.Traders See Bullish Options Activity Intercept Pharmaceuticals Inc.Detailed stock trading history of Akkaraju Srinivas (Intercept Pharmaceuticals Inc ).
Intercept Pharmaceuticals says a trial of its liver drug was halted early after it met its primary goal, sending ICPT stock up more than 280% Thursday.Intercept Pharmaceuticals Reports First Quarter 2016 Financial.
Intercept Pharmaceuticals LogoICPT Stock Quote, and financial news from the leading provider and award-winning MarketWatch.com.Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver.It focuses on the discovering, developing and commercializing of novel therapeutics...
Pipeline Novel compounds being developed for liver diseasesIntercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares.
... Buy Intercept Pharmaceuticals At $150, Earn 12% Using Options - ForbesTo help you get a sense of the short to long-term trend of Intercept Pharmaceuticals, there.
Srinivas Akkaraju M.D. Ph.D. - Executive Bio, Compensation History ...
Intercept Pharmaceuticals, Inc. issued a press release announcing.At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options.